Micron, Iris Energy, Trip.com Group And Other Big Stocks Moving Higher On Monday
Micron, Iris Energy, Trip.com Group And Other Big Stocks Moving Higher On Monday
美光、艾瑞斯能源、Trip.com集團和其他大股週一走高
U.S. stocks were lower, with the Dow Jones falling around 250 points on Monday.
美國股市走低,道瓊斯指數週一下跌約250點。
Shares of Micron Technology, Inc. (NASDAQ:MU) rose sharply during Monday's session after B of A Securities maintained a Buy rating on the stock and raised its price target from $120 to $144.
美光科技公司(納斯達克股票代碼:MU)的股價在週一的交易中大幅上漲,此前B類A證券維持該股的買入評級並將其目標股價從120美元上調至144美元。
Micron Technology shares climbed 6.6% to $125.69 on Monday.
週一,美光科技股價上漲6.6%,至125.69美元。
Here are some other big stocks recording gains in today's session.
以下是今天交易日其他一些上漲的大型股票。
- Doma Holdings Inc. (NYSE:DOMA) shares rose 34% to $6.08 after the company entered a merger transaction with TRG to go private at $6.29 per share in cash.
- Mesoblast Limited (NASDAQ:MESO) gained 22.4% to $6.13 after the FDA earlier in the week informed the company that the available clinical data from its Phase 3 study MSB-GVHD001 appears sufficient to support submission of the proposed Biologics License Application for remestemcel-L.
- SolarMax Technology, Inc. (NASDAQ:SMXT) rose 22.1% to $11.18.
- Ouster, Inc. (NYSE:OUST) shares jumped 19.8% to $9.51.
- Jiuzi Holdings, Inc. (NASDAQ:JZXN) gained 17.2% to $4.09.
- Ballard Power Systems Inc. (NASDAQ:BLDP) gained 16.4% to $3.2350 after the company announced the signing of a Long Term Supply Agreement with Solaris for the supply of 1,000 hydrogen fuel cell engines for the European transit bus market.
- Iris Energy Limited (NASDAQ:IREN) climbed 16% to $6.26. Cantor Fitzgerald analyst Josh Siegler reiterated Iris Energy with an Overweight and maintained a $10 price target.
- Allego N.V. (NASDAQ:ALLG) gained 15.2% to $1.67.
- GigaCloud Technology Inc. (NASDAQ:GCT) rose 13.3% to $30.26.
- ZimVie Inc. (NASDAQ:ZIMV) gained 12.6% to $18.56. ZimVie announced closing of sale of spine business to an affiliate of H.I.G. Capital for $375 million in total consideration.
- DouYu International Holdings Limited (NASDAQ:DOYU) gained 12% to $7.38.
- COMPASS Pathways plc (NASDAQ:CMPS) gained 10.6% to $9.20. Morgan Stanley analyst Vikram Purohit initiated coverage on Compass Pathways with an Overweight rating and announced a price target of $30.
- Coeur Mining, Inc. (NYSE:CDE) rose 9.6% to $4.1350 amid strength in precious metals stocks as gold rises on rate cut hopes.
- Trip.com Group Limited (NASDAQ:TCOM) climbed 7.6% to $47.24. Citigroup analyst Brian Gong maintained Trip.com Group with a Buy and raised the price target from $53 to $55.
- NexGen Energy Ltd. (NYSE:NXE) gained 7% to $8.31.
- Western Digital Corporation (NASDAQ:WDC) rose 5.7% to $72.13.
- The Chemours Company (NYSE:CC) gained 6.4% to $27.94. Chemours recently said it identified four material weaknesses amid its internal control over financial reporting.
- Doma Holdings Inc.(紐約證券交易所代碼:DOMA)股價上漲34%,至6.08美元,此前該公司與TRG進行了合併交易,以每股6.29美元的現金進行私有化。
- Mesoblast Limited(納斯達克股票代碼:MESO)上漲22.4%,至6.13美元,此前美國食品藥品管理局在本週早些時候告知該公司,其3期研究 MSB-GVHD001 的可用臨床數據似乎足以支持Remestemcel-L的擬議生物製劑許可證申請的提交。
- SolarMax Technology, Inc.(納斯達克股票代碼:SMXT)上漲22.1%,至11.18美元。
- Ouster, Inc.(紐約證券交易所代碼:OUST)股價上漲19.8%,至9.51美元。
- 九子控股有限公司(納斯達克股票代碼:JZXN)上漲17.2%,至4.09美元。
- 巴拉德動力系統公司(納斯達克股票代碼:BLDP)上漲16.4%,至3.2350美元,此前該公司宣佈與Solaris簽署長期供應協議,爲歐洲公交巴士市場供應1,000臺氫燃料電池發動機。
- 艾瑞斯能源有限公司(納斯達克股票代碼:IREN)上漲16%,至6.26美元。坎託·菲茨傑拉德分析師喬什·西格勒重申艾瑞斯能源增持,並維持10美元的目標股價。
- Allego N.V.(納斯達克股票代碼:ALLG)上漲15.2%,至1.67美元。
- GigaCloud Technology Inc.(納斯達克股票代碼:GCT)上漲13.3%,至30.26美元。
- ZimVie Inc.(納斯達克股票代碼:ZIMV)上漲12.6%,至18.56美元。ZimVie宣佈完成向H.I.G. Capital子公司出售脊柱業務,總對價爲3.75億美元。
- 鬥魚國際控股有限公司(納斯達克股票代碼:DOYU)上漲12%,至7.38美元。
- COMPASS Pathways plc(納斯達克股票代碼:CMPS)上漲10.6%,至9.20美元。摩根士丹利分析師維克拉姆·普羅希特以增持評級啓動了對Compass Pathways的報道,並宣佈目標股價爲30美元。
- 由於黃金因降息希望而上漲,貴金屬股走強,科爾礦業公司(紐約證券交易所代碼:CDE)上漲9.6%,至4.1350美元。
- 攜程集團有限公司(納斯達克股票代碼:TCOM)上漲7.6%,至47.24美元。花旗集團分析師布萊恩·貢維持Trip.com集團的買入,並將目標股價從53美元上調至55美元。
- NexGen Energy Ltd.(紐約證券交易所代碼:NXE)上漲7%,至8.31美元。
- 西部數據公司(納斯達克股票代碼:WDC)上漲5.7%,至72.13美元。
- 科慕公司(紐約證券交易所代碼:CC)上漲6.4%,至27.94美元。Chemours最近表示,它在財務報告的內部控制中發現了四個重大缺陷。
Now Read This: Insiders Buying Outlook Therapeutics And 2 Other Stocks
現在讀這個: 業內人士購買Outlook Therapeutics和其他2只
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。